Related scientific articles (all)

Crosstalk between HER2 signaling and angiogenesis in breast cancer: molecular basis, clinical applications and challenges.

Authors : Alameddine RS, Otrock ZK, Awada A, Shamseddine A
Year : 2013
Journal : Curr Opin Oncol
Volume : 25(3)
Pages : 313-24

Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study.

Authors : Berghmans T, Ameye L, Willems L, Paesmans M, Mascaux C, Lafitte JJ, Meert AP, Scherpereel A, Cortot AB, CsToth I, Dernies T, Toussaint L, Leclercq N, Sculier JP
Year : 2013
Journal : Lung Cancer
Volume : 82(2)
Pages : 340-5

Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells.

Authors : Kindt N, Laurent G, Nonclercq D, Journe F, Ghanem G, Duvillier H, Gabius HJ, Lechien J, Saussez S
Year : 2013
Journal : Int J Oncol
Volume : 43(1)
Pages : 185-93

Academic versus industry-driven research in upper gastrointestinal cancer: sinners and saints.

Authors : Hendlisz A, Charette N, Awada A, Deleporte A
Year : 2013
Journal : Curr Opin Oncol
Volume : 25(4)
Pages : 407-8

Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial.

Authors : de Azambuja E, Zardavas D, Lemort M, Rossari J, Moulin C, Buttice A, Dhondt V, Lebrun F, Lalami Y, Cardoso F, Sotiriou C, Gil T, Devriendt D, Paesmans M, Piccart-Gebhart M, Awada A
Year : 2013
Journal : Ann Oncol
Volume : 24(12)
Pages : 2985-9

Supportive care in cancer patients: a unifying concept.

Authors : Klastersky J
Year : 2013
Journal : Curr Opin Oncol
Volume : 25(4)
Pages : 341

Safety and efficacy of neratinib (HKI-272) plus vinorelbine in the treatment of patients with ErbB2-positive metastatic breast cancer pretreated with anti-HER2 therapy.

Authors : Awada A, Dirix L, Manso Sanchez L, Xu B, Luu T, Diéras V, Hershman DL, Agrapart V, Ananthakrishnan R, Staroslawska E
Year : 2013
Journal : Ann Oncol
Volume : 24(1)
Pages : 109-16

Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis.

Authors : Nagalla S, Chou JW, Willingham MC, Ruiz J, Vaughn JP, Dubey P, Lash TL, Hamilton-Dutoit SJ, Bergh J, Sotiriou C, Black MA, Miller LD
Year : 2013
Journal : Genome Biol.
Volume : 14(4)
Pages : R34

Topoisomerase Inhibitors in Metastatic Breast Cancer: Overview of Current Practice and Future Development

Authors : Vanderbeeken MC, Aftimos P, Awada A
Year : 2013
Journal : Current Breast Cancer Rep
Volume : 5
Pages : 31-41

Systems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and swarm intelligence""

Authors : Tarabichi M, Antoniou A, Saiselet M, Pita JM, Andry G, Dumont JE, Detours V, Maenhaut C
Year : 2013
Journal : Cancer Metastasis Rev
Volume : 32(3-4)
Pages : 403-21

Observation of a cytopathogenic effect on cell lines used for routine viral cultures led to the diagnosis of lymphogranuloma venereum.(epub online dec 2012)

Authors : Busson L, Crucitti T, De Foor M, Van den Wijngaert S, Vandenberg O
Year : 2013
Journal : Sex Transm Infect
Volume : 89(5)
Pages : 395-7

Quality assurance in head and neck surgical oncology: EORTC 24954 trial on larynx preservation.

Authors : Leemans CR, Tijink BM, Langendijk JA, Andry G, Hamoir M, Lefebvre JL
Year : 2013
Journal : Eur J Surg Oncol
Volume : 39(9)
Pages : 1013-8

An ethnobotanical survey of medicinal plants used in Rwanda for voluntary depigmentation.

Authors : Kamagaju L, Bizuru E, Minani V, Morandini R, Stévigny C, Ghanem G, Duez P
Year : 2013
Journal : J Ethnopharmacol
Volume : 150(2)
Pages : 708-17

Nonsmall cell lung cancer.

Authors : Sculier JP
Year : 2013
Journal : Eur Respir Rev
Volume : 22(127)
Pages : 33-6

Impressive response to eribulin in endocrine- and chemotherapy resistant metastatic breast cancer

Authors : Vanderbeeken MC, de Azambuja E
Year : 2013
Journal : Belgian J Medical Oncology
Volume : 7(1)
Pages : 27-30

Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients.

Authors : Bertucci F, Finetti P, Roche H, Le Doussal JM, Marisa L, Martin AL, Lacroix-Triki M, Blanc-Fournier C, Jacquemier J, Peyro-Saint-Paul H, Viens P, Sotiriou C, Birnbaum D, Penault-Llorca F
Year : 2013
Journal : Ann Oncol
Volume : 24(3)
Pages : 625-32

ESUT expert group on laparoscopy proposes uniform terminology during radical prostatectomy: we need to speak the same language.

Authors : Rassweiler J, Laguna MP, Chlosta P, Pansadoro V, Gaboardi F, Stolzenburg JU, Barret E, Liatsikos EN, Tunc L, Frede T, John H, Bachmann A, Van Velthoven R
Year : 2013
Journal : Eur Urol
Volume : 64(1)
Pages : 97-100

Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib.

Authors : La Rosée P, Martiat P, Leitner A, Klag T, Müller MC, Erben P, Schenk T, Saussele S, Hochhaus A
Year : 2013
Journal : Ann Hematol
Volume : 92(10)
Pages : 1345-50

Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digestive Oncology.

Authors : Borbath I, Ceratti A, Verslype C, Demols A, Delaunoit T, Laurent S, Deleporte A, Vergauwe P, Van Maanen A, Sempoux C, van Cutsem E, Van Laethem JL
Year : 2013
Journal : Ann Oncol
Volume : 24(11)
Pages : 2824-9

Pitfalls of monoclonal gammopathy.

Authors : Meuleman N
Year : 2013
Journal : Rev Med Brux
Volume : 34(4)
Pages : 335-8